Cryofocus Medtech (Shanghai) Co., Ltd. (Stock Code: 6922) concluded its 2025 first extraordinary general meeting (EGM) on October 31, 2025. Shareholders holding a total of 131,774,144 shares, representing approximately 55.11% of the total issued shares, were present in person or by proxy. All resolutions put forth were adopted by way of poll with a majority exceeding two-thirds.

The EGM approved amendments to the Articles of Association, which took effect immediately. Concurrently, the Supervisory Committee was abolished on the same date, and its powers and responsibilities will be assumed by the Audit Committee going forward. Each supervisor resigned effective upon the EGM’s conclusion, and there were no reported disagreements during their service.

All directors attended the meeting, and the company’s H share registrar and the company served as scrutineers for the poll. The revised Articles of Association will be accessible on the company’s website and the Hong Kong Stock Exchange website.